GERM vs. EQRR
GERM (Amplify Treatments, Testing and Advancements ETF) and EQRR (ProShares Equities for Rising Rates ETF) are both exchange-traded funds - GERM is a Health & Biotech Equities fund tracking the Prime Treatments, Testing and Advancements Index, while EQRR is a Mid Cap Value Equities fund tracking the Nasdaq US Large Cap Equity Rising Rates Index. Both are passively managed. Over the past year, GERM returned 0.00% vs 38.66% for EQRR. GERM charges 0.68%/yr vs 0.35%/yr for EQRR.
Performance
GERM vs. EQRR - Performance Comparison
Loading charts...
Returns By Period
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
EQRR
- 1D
- 0.63%
- 1M
- 3.23%
- YTD
- 27.06%
- 6M
- 25.94%
- 1Y
- 38.66%
- 3Y*
- 22.17%
- 5Y*
- 13.17%
- 10Y*
- —
GERM vs. EQRR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
EQRR ProShares Equities for Rising Rates ETF | 27.06% | 15.49% | 0.58% |
GERM vs. EQRR - Sectors Allocation Comparison
Sectors
GERM
EQRR
Healthcare
-
Financial Services
Basic Materials
-
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
GERM
EQRR
-
Financial Services
GERM
EQRR
Basic Materials
GERM
-
EQRR
-
Communication Services
GERM
-
EQRR
Consumer Cyclical
GERM
-
EQRR
Consumer Defensive
GERM
-
EQRR
-
Energy
GERM
-
EQRR
Industrials
GERM
-
EQRR
Real Estate
GERM
-
EQRR
-
Technology
GERM
-
EQRR
Utilities
GERM
-
EQRR
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GERM vs. EQRR — Risk / Return Rank
GERM
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
EQRR
GERM vs. EQRR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and ProShares Equities for Rising Rates ETF (EQRR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GERM | EQRR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.48 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 7.85 | — |
| Martin ratioReturn relative to average drawdown | — | 27.39 | — |
Loading charts...
Drawdowns
GERM vs. EQRR - Drawdown Comparison
The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum EQRR drawdown of -57.93%. Use the drawdown chart below to compare losses from any high point for GERM and EQRR.
Loading charts...
Drawdown Indicators
| GERM | EQRR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -57.93% | +57.93% |
Max Drawdown (1Y)Largest decline over 1 year | 0.00% | -4.95% | +4.95% |
Max Drawdown (3Y)Largest decline over 3 years | — | -17.75% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -21.75% | — |
Current DrawdownCurrent decline from peak | 0.00% | -0.86% | +0.86% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -10.03% | +10.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.00% | 1.42% | -1.42% |
Volatility
GERM vs. EQRR - Volatility Comparison
The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while ProShares Equities for Rising Rates ETF (EQRR) has a volatility of 7.03%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than EQRR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GERM | EQRR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 7.03% | -7.03% |
Volatility (6M)Calculated over the trailing 6-month period | 0.00% | 11.56% | -11.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 14.50% | -14.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 21.40% | -21.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 24.87% | -24.87% |
GERM vs. EQRR - Expense Ratio Comparison
GERM has a 0.68% expense ratio, which is higher than EQRR's 0.35% expense ratio.
Dividends
GERM vs. EQRR - Dividend Comparison
GERM has not paid dividends to shareholders, while EQRR's dividend yield for the trailing twelve months is around 1.21%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
EQRR ProShares Equities for Rising Rates ETF | 1.21% | 1.70% | 2.17% | 2.77% | 2.34% | 1.71% | 2.17% | 2.05% | 2.47% | 0.69% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
EQRR has higher volatility (7.03%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs EQRR's -57.93%.
On 1-year performance, EQRR leads with 38.66% vs 0.00% for GERM. On fees, EQRR is cheaper at 0.35% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, EQRR has performed better with a 38.66% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
EQRR is cheaper with a 0.35% expense ratio, compared with 0.68% for GERM.
EQRR has the higher dividend yield at 1.21%, compared with 0.00% for GERM.
GERM is categorized as Health & Biotech Equities, while EQRR is Mid Cap Value Equities. GERM tracks Prime Treatments, Testing and Advancements Index, while EQRR tracks Nasdaq US Large Cap Equity Rising Rates Index. They also come from different issuers: Amplify and ProShares. Their fees differ too: 0.68% for GERM and 0.35% for EQRR.
Find the right allocation for GERM and EQRR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer